New study sheds light on incidental findings in lung cancer screening

byBrown UniversityCredit: Pixabay/CC0 Public DomainWhen patients receive a low-dose computed tomography screen for lung cancer, doctors can see more than just the lungs. The screening test often

Updated on: January 13,2024 20

New study sheds light on incidental findings in lung cancer screening

byBrown UniversityCredit: Pixabay/CC0 Public DomainWhen patients receive a low-dose computed tomography screen for lung cancer, doctors can see more than just the lungs. The screening test often

Updated on:January 13,2024 20

Breast cancer spread uncovered by new molecular microscopy

byWellcome Trust Sanger InstituteConverting BaSISS spatial signals into maps of clones.a, Bar plots of cancer cell fractions (CCFs) derived from bulk WGS of the P1 samples.b, P

Updated on: January 11,2024 10

Breast cancer spread uncovered by new molecular microscopy

byWellcome Trust Sanger InstituteConverting BaSISS spatial signals into maps of clones.a, Bar plots of cancer cell fractions (CCFs) derived from bulk WGS of the P1 samples.b, P

Updated on:January 11,2024 10

Anti-worm drug inhibits tumor growth and spread in mice

by University of New South WalesResearchers at UNSW Sydney have discovered that a drug used for almost 40 years to treat worm infections in humans and animals can be used to inhibit melanoma grow

Updated on: March 12,2024 16

Anti-worm drug inhibits tumor growth and spread in mice

by University of New South WalesResearchers at UNSW Sydney have discovered that a drug used for almost 40 years to treat worm infections in humans and animals can be used to inhibit melanoma grow

Updated on:March 12,2024 16

Convection-enhanced delivery of topotecan active in glioblastoma

by Elana GotkineA subcutaneously implanted, catheter-pump system capable of chronic convection-enhanced delivery (CED) of topotecan is well tolerated and active for patients with recurrent glioblastom

Updated on: January 30,2024 20

Convection-enhanced delivery of topotecan active in glioblastoma

by Elana GotkineA subcutaneously implanted, catheter-pump system capable of chronic convection-enhanced delivery (CED) of topotecan is well tolerated and active for patients with recurrent glioblastom

Updated on:January 30,2024 20

Research identifies new way to halt pancreatic cancer invasion by targeting healthy cells

by Queen Mary, University of LondonInhibition of FGFR1 limits invasion in pre-clinical models of PDAC.ARepresentative H&E images of MIA PaCa-2: PS1 organotypics treated with 100 n

Updated on: February 20,2024 14

Research identifies new way to halt pancreatic cancer invasion by targeting healthy cells

by Queen Mary, University of LondonInhibition of FGFR1 limits invasion in pre-clinical models of PDAC.ARepresentative H&E images of MIA PaCa-2: PS1 organotypics treated with 100 n

Updated on:February 20,2024 14

How conquering a rare leukemia in children revolutionized cancer care for millions

by Marie McculloughFifty years ago, children with an aggressive form of leukemia went from diagnosis to death in a few months, as the disease rampaged through their lymph nodes, spleens, livers, and n

Updated on: March 01,2024 19

How conquering a rare leukemia in children revolutionized cancer care for millions

by Marie McculloughFifty years ago, children with an aggressive form of leukemia went from diagnosis to death in a few months, as the disease rampaged through their lymph nodes, spleens, livers, and n

Updated on:March 01,2024 19

Physicians IDs barriers to 'no antibiotic' strategy for pediatric viral pneumonia

by Elana GotkineThere are considerable barriers relating to implementation of a "no antibiotic" strategy for mild community-acquired pneumonia (CAP) in children, according to a study publish

Updated on: May 07,2024 15

Physicians IDs barriers to 'no antibiotic' strategy for pediatric viral pneumonia

by Elana GotkineThere are considerable barriers relating to implementation of a "no antibiotic" strategy for mild community-acquired pneumonia (CAP) in children, according to a study publish

Updated on:May 07,2024 15

Overlooked strategy shows promise for treating KRAS-mutated colon cancer

Updated on: June 14,2025 0

Overlooked strategy shows promise for treating KRAS-mutated colon cancer

Updated on:June 14,2025 0

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which

Updated on: July 17,2024 0

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which

Updated on:July 17,2024 0

Researchers ID risks for second childhood cancers

by Jeremy OlsonCredit: CC0 Public DomainChemotherapy and radiation treatments have helped children survive cancer. Now University of Minnesota researchers are trying to find the ideal combinations tha

Updated on: June 22,2024 7

Researchers ID risks for second childhood cancers

by Jeremy OlsonCredit: CC0 Public DomainChemotherapy and radiation treatments have helped children survive cancer. Now University of Minnesota researchers are trying to find the ideal combinations tha

Updated on:June 22,2024 7

Blood test spots early pancreatic cancers with 97% accuracy

by Dennis ThompsonA blood test appears capable of detecting early-stage pancreatic cancers with up to 97% accuracy, a new study reports.The test looks for eight small RNA particles and eight larger DN

Updated on: April 28,2024 0

Blood test spots early pancreatic cancers with 97% accuracy

by Dennis ThompsonA blood test appears capable of detecting early-stage pancreatic cancers with up to 97% accuracy, a new study reports.The test looks for eight small RNA particles and eight larger DN

Updated on:April 28,2024 0

Research shows PSMA PET/CT imaging changes management for close to 50% of prostate cancer patients

by Society of Nuclear Medicine and Molecular ImagingGraphical Abstract: Patients with detectable PSA (0.2-2.0 ng/mL) post-prostatectomy considered for salvage radiotherapy undergoing18F-DCFPyL P

Updated on: January 22,2024 15

Research shows PSMA PET/CT imaging changes management for close to 50% of prostate cancer patients

by Society of Nuclear Medicine and Molecular ImagingGraphical Abstract: Patients with detectable PSA (0.2-2.0 ng/mL) post-prostatectomy considered for salvage radiotherapy undergoing18F-DCFPyL P

Updated on:January 22,2024 15